The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Stimulant Therapy and Risk for Subsequent Substance Use Disorders in Male Adults With ADHD: A Naturalistic Controlled 10-Year Follow-Up Study
Abstract
OBJECTIVE: The extant literature does not provide definite answers pertaining to whether stimulant treatment increases, decreases, or does not affect the risk for subsequent substance use disorders in youths with attention deficit hyperactivity disorder (ADHD). The authors examined the association between stimulant treatment in childhood and adolescence and subsequent substance use disorders (alcohol, drug, and nicotine) into the young adult years. METHOD: The authors conducted a 10-year prospective follow-up study. One hundred forty male Caucasian children with ADHD, ages 6 to 17, were examined at baseline. Of these, 112 (80%) were reassessed at the 10-year follow-up (mean age at follow-up=22 years). Assessments were made using Cox proportional hazards survival models. All models were adjusted for conduct disorder, since conduct disorder is a potent predictor of subsequent substance use disorders. RESULTS: Of the 112 ADHD subjects who were reassessed at the 10-year follow-up, 82 (73%) had been treated previously with stimulants and 25 (22%) were undergoing stimulant treatment at the time of the follow-up assessment. There were no statistically significant associations between stimulant treatment and alcohol, drug, or nicotine use disorders. CONCLUSIONS: The findings revealed no evidence that stimulant treatment increases or decreases the risk for subsequent substance use disorders in children and adolescents with ADHD when they reach young adulthood.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although clinical studies have examined stimulant therapy for ADHD and subsequent risk for SUD, [30][31][32][33][34][35][36] these studies suffer from limitations such as small homogeneous samples, non-random sampling, and lack of attention toward both non-stimulant and stimulant therapy for ADHD.”
From Is Age of Onset and Duration of Stimulant Therapy for ADHD Associated with Cocaine, Methamphetamine, and Prescription Stimulant Misuse? (2024) · cites this paper as [32]
In the citing paper
“Although many studies seem to find no or possibly protective effects of ADHD medication on substance use (Barkley, Fischer, Smallish, & Fletcher, 2003; Biederman et al., 2008; Faraone & Wilens, 2007; Mannuzza, et al., 2008; Wilens, Faraone, Biederman, & Gunawardene, 2003), they have had limited sample sizes and data are as yet inconclusive.”
From Stimulant ADHD medication and risk for substance abuse (2014) · cites this paper as Biederman et al., 2008
In the citing paper
“neutral or protective effects on sub sequent drug and alcohol use disorders 172-175 .”
From Attention-deficit/hyperactivity disorder (2015) · cites this paper as [172]
In the citing paper
“A meta-analytic review of six studies suggested that stimulant therapy in childhood may be associated with a reduction in risk, compared to unmedicated ADHD subjects, for subsequent drug and alcohol use disorders (HR = 1.9), with a stronger effect during adolescence (HR = 5.8) than adulthood follow-up (HR = 1.4) [155]; however, when this group was re-examined a further 5 years later no significant”
From European guidelines on managing adverse effects of medication for ADHD (2011) · cites this paper as [21]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
&NA; (1988) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-198802020-00022 · Cited by 12,526
The neural basis of drug craving: An incentive-sensitization theory of addiction
Robinson, T. (1993) · Brain Research Reviews · doi:10.1016/0165-0173(93)90013-p · Cited by 7,346
Four Factor Index of Social Status
Paschou, R. (1975) · Cited by 6,988
Four Factor Index of Social Status [1975]
Hollingshead, A. B. (1975) · Cited by 5,151
Structured Clinical Interview for DSM-IV Axis I Disorders
Spitzer, R. L., First, M. B., & Gibbon, M. (1997) · Medical Entomology and Zoology · Cited by 3,582
General hospital psychiatry: the Italian experience.
Faraone, S. V., Sergeant, J. A., Gillberg, C., & Biederman, J. (2003) · Europe PMC (PubMed Central) · Cited by 1,287
Self-citationWilens, T. E., Faraone, S. V., Biederman, J., & Gunawardene, S. (2003) · Pediatrics · doi:10.1542/peds.111.1.179 · Cited by 872
Self-citationBiederman, J., Mick, E., Faraone, S. V., Braaten, E., Doyle, A., Spencer, T., Wilens, T. E., Frazier, E., & Johnson, M. A. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.1.36 · Cited by 863
Self-citationBIEDERMAN, J., MONUTEAUX, M. C., MICK, E., SPENCER, T., WILENS, T. E., SILVA, J. M., SNYDER, L. E., & FARAONE, S. V. (2006) · Psychological Medicine · doi:10.1017/s0033291705006410 · Cited by 850
Self-citationBiederman, J. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820090056010 · Cited by 771
Self-citation
Research works printed but not linked: 7
- Faraone SV, 2003, World Psychiatry, 2, 104
- Lambert NM, 2002, Civic Research Institute, 1
- Lambert NM, 1998, NIH Consensus Development Conference Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder. Bethesda, Md, NIH, 191
- Faraone SV, 2003, J Clin Psychiatry, 64, 9
- Fischer M, 2003, J Clin Psychiatry, 64, 19
- Orvaschel H, 1994, Epidemiologic Version. Ft. Lauderdale, Fla
- Hintze JL, 2005, NCSS
Cited by
Attention-deficit/hyperactivity disorder
Faraone, S. V., Asherson, P., Banaschewski, T., Biederman, J., Buitelaar, J. K., Ramos-Quiroga, J. A., Rohde, L. A., Sonuga-Barke, E. J. S., Tannock, R., & Franke, B. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.20 · Cited by 1,479
Self-citationAttention‐Deficit‐Hyperactivity Disorder: An Update
Dopheide, J. A., & Pliszka, S. R. (2009) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.29.6.656 · Cited by 645
“It is possible that early stimulant treatment of ADHD has a protective effect toward the emergence of conduct disorder, which usually precedes antisocial personality disorder and increases the risk for delinquency and drug abuse.(14) Oppositional defiant disorder associated with ADHD is responsive to drug treatment, a…”
Backgroundvan Emmerik-van Oortmerssen, K., van de Glind, G., van den Brink, W., Smit, F., Crunelle, C. L., Swets, M., & Schoevers, R. A. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.12.007 · Cited by 535
“In a study by Biederman and colleagues (Biederman et al., 2008) in which children with ADHD were followed up into young adulthood, no evidence was found that stimulant treatment affects the risk of subsequent SUD, but in two other prospective studies (Mannuzza et al., 2008a,b; Wilens et al.,…”
BackgroundEuropean guidelines on managing adverse effects of medication for ADHD
(for the European Guidelines Group), Graham, J., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Dittmann, R. W., Döpfner, M., Hamilton, R., Hollis, C., et al. (2011) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-010-0140-6 · Cited by 374
“Other studies show either no influence of methylphenidate or a reduction of risk; in one study only when stimulant treatment had been initiated before puberty [21, 38, 53, 65, 86].”
BackgroundResultAttention-deficit/hyperactivity disorder and adverse health outcomes
Nigg, J. T. (2013) · Clinical Psychology Review · doi:10.1016/j.cpr.2012.11.005 · Cited by 436
Metadata
- Authors
- Biederman, J., Monuteaux, M. C., Spencer, T., Wilens, T. E., MacPherson, H. A., & Faraone, S. V.
- Affiliations
- Harvard University (US)
- Venue
- American Journal of Psychiatry
- Published
- 2008-05
- Volume
- 165
- Issue
- 5
- Pages
- 597-603
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2124484608
- Cited by
- 239
- References
- 28
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 5 · 2023: 8 · 2022: 6 · 2021: 6 · 2020: 8 · 2019: 15 · 2018: 3 · 2017: 14 · 2016: 12 · 2015: 10 · 2014: 16 · 2013: 15 · 2012: 34
- FWCI
- 17.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (K24DA016264)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD036317, 5R01 HD36317)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
- Keywords
- attention deficit hyperactivity disorder, stimulant medication, substance use disorders, alcoholism, drug use disorders, nicotine use disorder, young adults, conduct disorder, long-term follow-up, children and adolescents
- MeSH terms
- Adolescent, Adult, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Child, Follow-Up Studies, Humans, Male, Prospective Studies, Risk Factors, Incidence, Prevalence, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Stimulant Therapy and Risk for Subsequent Substance Use Disorders in Male Adults With ADHD: A Naturalistic Controlled 10-Year Follow-Up Study. https://app.cochat.ai/papers/10.1176/appi.ajp.2007.07091486
- The paper
- Biederman, J., Monuteaux, M. C., Spencer, T., Wilens, T. E., MacPherson, H. A., & Faraone, S. V. (2008). Stimulant Therapy and Risk for Subsequent Substance Use Disorders in Male Adults With ADHD: A Naturalistic Controlled 10-Year Follow-Up Study. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.2007.07091486
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.